Jack Beyer

Jack has served as Vanqua Bio’s Chief Business Officer since April 2021. Prior to joining Vanqua Bio, he was an investment professional on the private equity team at OrbiMed Advisors LLC, a healthcare investment firm. Prior to OrbiMed, he was an equity research associate at Citi, covering medical device companies. He holds a B.A. cum laude in economics from Boston College.